热门资讯> 正文
捷普收购Pharmaceutics International
2025-02-04 21:37
- Jabil (NYSE:JBL) on Tuesday announced the acquisition of Pharmaceutics International, a contract development and manufacturing organization.
- Pharmaceutics International specializes in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing.
- JBL +1.29% premarket to $161.55.
- Source: Press Release
More on Jabil
- Jabil: Growth Acceleration To Be Driven By AI Revenue
- Corporate candidates to announce accelerate share buybacks: Trivariate
- Top S&P, Nasdaq winners as Wall Street breaks losing streak with 2025 action underway
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
